The effect of isolated tumor cells on adjuvant treatment decisions for patients with endometrial cancer: A retrospective case series
Open Access
- 1 March 2025
- journal article
- Published by Elsevier in Gynecologic Oncology Reports
- Vol. 58, 101713
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Lymph Node Isolated Tumor Cells in Patients With Endometrial CancerJAMA Network Open, 2024
- Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAnnals of Oncology, 2023
- FIGO staging of endometrial cancer: 2023International Journal of Gynecology & Obstetrics, 2023
- Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort studyGynecologic Oncology, 2021
- Oncologic outcomes of endometrial cancer in patients with low-volume metastasis in the sentinel lymph nodes: An international multi-institutional studyGynecologic Oncology, 2021
- Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I/II endometrioid endometrial cancer: To treat or not to treat?Gynecologic Oncology, 2021
- Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?Gynecologic Oncology, 2017
- Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancerGynecologic Oncology, 2016
- Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: A French sentinel node multicenter cohort studyThe Breast, 2014
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004